BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, December 21, 2025
See today's BioWorld MedTech
Home
» Analysts see Staar on the verge of significant top line growth
To read the full story,
subscribe
or
sign in
.
Analysts see Staar on the verge of significant top line growth
March 2, 2012
By
Omar Ford
Analysts at Canaccord Genuity are saying that Staar Surgical (Monrovia, California) could be poised for tremendous growth in the med-tech sector throughout the next few years.
BioWorld MedTech